Yahoo Finance Global Neurostimulation Devices Market Size to Increase by $8.7 Billion By 2028: According to Vantage Market Research
WASHINGTON, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The human body's central nervous system (CNS) and peripheral nervous system (PNS) are both affected by neurological conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and cerebrovascular diseases. Neurostimulation technology is essential for treating some neurological issues. The electrodes in the gadgets produce gentle electrical impulses to support the patients' neurological activity. These devices can either be external or implanted. The brain, PNS, or CNS, is the direct placement site for Neurostimulation Devices Market. Hence, the rising geriatric population suffering from chronic diseases is driving the market growth. The Global Market revenue was valued at USD 4.3 Billion in 2021.
The Global Neurostimulation Devices Market size is forecast to reach USD 8.7 Billion by 2028 and is expected to grow to exhibit a CAGR (Compound Annual Growth Rate) of 12.5% during the forecast period; states Vantage Market Research, in a report, titled “Neurostimulation Devices Market Size, Share & Trends Analysis Report by Product Type (Spinal Cord Stimulators, Deep Brain Stimulators, Cochlear Implants, Vagus Nerve Stimulators), by Application (Chronic Pain, Movement Disorders, Hearing Impairment, Epilepsy), by End Users (Hospitals, Ambulatory Surgery Centers, Specialty Clinics), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”.
Get Sample Copy of This Report: https://www.vantagemarketresearch.com/neurostimulation-devices-market-1851/request-sample
List of Prominent Players in Neurostimulation Devices Market:
Boston Scientific Corporation
Medtronic PLC
Abbott Laboratories
Nevro Corp.
Liva Nova PLC
Axonics Modulation Technologies Inc.
Neuropace Inc.
EndoStimInc.
NDI Medical
Cochlear Limited
Neuronetics Inc.
Market Dynamics:
Drivers:
Increase Prevalence of Chronic Diseases
The market for Neurostimulation Devices Market is expanding due to factors such as the rising prevalence of lifestyle diseases like depression and chronic pain, the rise in neurological disorders, and investments in neurological R&D. Additionally; the market is being driven by the surge in demand for minimally invasive surgery, the adoption of technologically advanced products, and the growing elderly population, who are more susceptible to neurological disorders like epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain. However, the implantation of Neurostimulation Devices Market into the body might cause adverse effects like allergic response and tingling or prickling of the skin, and the cost of devices is projected to rise, which will impede market expansion. Additionally, the availability of alternative treatments, including medical procedures and medication therapy, limits market expansion. On the other hand, research into the use of neurostimulators for treating conditions like obsessive-compulsive disorders, interstitial cystitis, and asthma is still ongoing and is anticipated to open up lucrative opportunities for the market expansion of Neurostimulation Devices Market in the years to come.
Increasing Geriatric Population and Rising Technological Advancements
According to projections from the UN Department of Economic and Social Affairs, there will be an increase in the number of elderly people worldwide from 7.7 billion to 9.7 billion by 2050. The geriatric population is likewise expanding steadily in terms of Parkinson's and Alzheimer's disease. The global market for Neurostimulation Devices Market will have significant growth potential due to the growing geriatric populations in developing nations like China and India. Over 20% of the population in Japan is over 65, according to a survey.
The market's potential for expansion will be further fueled by extensive R&D efforts for the creation of novel items and cutting-edge technology. For instance, Neurowave Medical Technologies created a transdermal neuromodulation device with a low level of invasiveness to treat patients with nausea and vomiting. The device intends to enhance the quality of life for patients receiving yearly chemotherapy-radiation therapy. In addition, the potential for extending market growth will be further increased by new innovations, including deep brain stimulation, spinal cord stimulation, sacral nerve stimulation, and vagus nerve stimulation.
Key Industry Findings & Insights from the report:
The Global Neurostimulation Devices Market was valued USD 4.3 Billion in 2021 and is all set to surpass USD 8.7 Billion by 2028, exhibiting a CAGR of 12.5% during the forecast period 2022-2028.
In terms of revenue, the application segment held the largest revenue share of in 2021 and is estimated to maintain its dominance for the forecast period.
In terms of revenue, the product segment held the second largest market share of in 2021 and is estimated to grow rapidly during the forecast period.
The growth can be attributed to rapid urbanization, technological advancement, an increase in investment by developing countries.
Asia Pacific captured the lion share in 2021 and is projected to retain its position over the forecast period. This can be attributed to the existence of a significant number of Neurostimulation Devices industry companies and the high adoption rate owing to government measures that stimulate this industry in this region. The growth is primarily due to the increasing collaborations.
Purchase This Premium Report (Price 4500 USD for a single-user license) at @ https://www.vantagemarketresearch.com/buy-now/neurostimulation-devices-market-1851/0
COVID-19 Impact Analysis:
The COVID-19 outbreak has affected various industries worldwide and the Global Neurostimulation Devices Market is not an exception. Governments across the world implemented several measures like strict lockdown to ensure social distancing norms to restrict the swift spread of the pandemic. The Neurostimulation Devices Market suffered as the manufacturing units around the world were forced to shut down during the initial stages of the pandemic. Small and medium-scale companies which are the backbone technology providers to the Neurostimulation Devices Market industry were directly affected due to the epidemic. Furthermore, the rollout for the Neurostimulation Devices Market industry too is taken into consideration as the aftereffects of the pandemic are gradually coming down since the beginning of 2022.
The situation is seen to improve in the second half of 2022 as more supplies resume normal. Vantage Market Research, while performing the analysis study for the Global Neurostimulation Devices Market has considered the impact of COVID-19 on the Neurostimulation Devices Market globally and the subsidiaries for the Neurostimulation Devices Market industry. In addition, the demand and supply chain are considered while estimating the current and forecast market size for the Global Neurostimulation Devices Market industry for all the regions and countries based on the following data points:
1. Impact Assessment of COVID-19 Pandemic
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
2. Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021
3. Key Strategies Undertaken by Companies to Tackle COVID-19
4. Long-Term Dynamics
5. Short-Term Dynamics
The report on Neurostimulation Devices Market highlights:
Assessment of the market
Premium Insights
Competitive Landscape
COVID Impact Analysis
Historic Data, Estimates, and Forecast
Company Profiles
For Any Query Regarding the Neurostimulation Devices Market Report? Contact Us at @ https://www.vantagemarketresearch.com/neurostimulation-devices-market-1851/inquiry-before-buying
Regional Analysis:
North America is expected to dominate the growth of Neurostimulation Devices Market in 2021. Significant market trends in North America include the creation of novel neurostimulators, the approval of novel neurostimulator procedures by health authorities, and mergers & acquisitions to acquire novel technologies & goods. The market in this region is anticipated to be driven by an increase in the frequency of neurological illnesses, growth in the elderly population, advantageous reimbursement rates, and the introduction of cutting-edge technologies. Additionally, it is anticipated that research and development efforts to create new technologies to treat neurological conditions like Parkinson's disease, dystonia, and epilepsy will expand the range of available treatments for patients and surgeons in the neurostimulation market. Future market growth is anticipated to be steady.
Browse market data Tables and Figures spread through 141 Pages and in-depth TOC on "Neurostimulation Devices Market Size, Share & Trends Analysis Report by Product Type (Spinal Cord Stimulators, Deep Brain Stimulators, Cochlear Implants, Vagus Nerve Stimulators), by Application (Chronic Pain, Movement Disorders, Hearing Impairment, Epilepsy), by End Users (Hospitals, Ambulatory Surgery Centers, Specialty Clinics), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".
Recent Developments:
February 2022 – Precisis announced that it received the US FDA approval for its breakthrough device designation for minimally invasive epilepsy treatment EASEE (Epicranial Application of Stimulation Electrodes for Epilepsy).
Jan 2021 – Abbott announced the upcoming launch of Neuso Spheremy Path which is aimed to track and report on patient-perceived pain relief and general well-being associated with conditions related to Spinal Cord Stimulation (SCS).
Key Questions Answered in The Report:
Which region will show the fastest and highest growth in the near future?
Which are the top five players and their weakness and strength of the Market?
What will be the future innovation in the upcoming six years?
Which application and product will lead the largest share of the Market?
What are the growth drivers, restraints and challenges of the industry?
What will be the CAGR and size of the Neurostimulation Devices Market for the base year and forecast period?
This market titled “Neurostimulation Devices Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:
Parameter | Details |
Market Size Provided for Years | 2016-2028 |
Base Year | 2021 |
Historic Years | 2016-2020 |
Forecast Years | 2022-2028 |
Segments Covered |
|
Region & Counties Covered |
|
Companies Covered |
|
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis |
Customization of the Report:
The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
Browse More Related Report:
Multiple Sclerosis Drugs Market: Multiple Sclerosis Drugs Market is valued at USD 25.1 Billion in 2021 and is projected to reach a value of USD 31.2 Billion by 2028 at a CAGR of 3.7% over the forecast period.
Nuclear Medicine Market: Nuclear Medicine Market was valued at USD 7.8 Billion in 2021 and is forecast to reach a value of USD 15.2 Billion by 2028. In the forecast period, the Global Market is anticipated to grow to exhibit a Compound Annual Growth Rate (CAGR) of 12.7%.
Healthcare Distribution Market: Healthcare Distribution Market was valued at USD 758.5 Billion in the year 2021 and is projected to reach a value of USD 1088.1 Billion by the year 2028. The Global Market is anticipated to grow to exhibit a Compound Annual Growth Rate (CAGR) of 6.2% over the forecast period.
Pharmaceutical Filtration Market: Pharmaceutical Filtration Market was valued at USD 10.1 Billion in 2021 and is anticipated to reach a value of USD 24.9 Billion by 2028. The Global Market is forecasted to grow to exhibit a Compound Annual Growth Rate (CAGR) of 16.3% over the forecast period.
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research reports. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
Follow Us on Facebook: https://www.facebook.com/vantagemarketresearch
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: sales@vantagemarketresearch.com
Website: https://www.vantagemarketresearch.com/
Latest Vantage Market Research Press Releases @https://www.vantagemarketresearch.com/insight/press-releases
Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs
Blog:
